期刊
EMBO JOURNAL
卷 28, 期 5, 页码 578-590出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/emboj.2009.1
关键词
calreticulin; caspase; endoplasmic reticulum stress; ERp57; exocytosis
资金
- Ligue Nationale contre le Cancer (Equipe labellisee)
- European Commission
- Canceropole Ile-de-France
- Fondation de France and Fondation pour la Recherche Medicale
- Swedish Research Council (Vetenskapsra det)
- Poste d'accueil INSERM
- EMBO
- CIHR Training Program in the Structural Biology of Membrane Proteins Linked to Disease
- CIHR and Canadian Cancer Society
- Fonds zur Forderung der wissenschaftlichen Forschung (Austria)
- Fonds zur Forderung der wissenschaftlichen Forschung (Austria) [S-9304-B05]
Dying tumour cells can elicit a potent anticancer immune response by exposing the calreticulin (CRT)/ERp57 complex on the cell surface before the cells manifest any signs of apoptosis. Here, we enumerate elements of the pathway that mediates pre-apoptotic CRT/ERp57 exposure in response to several immunogenic anticancer agents. Early activation of the endoplasmic reticulum (ER)-sessile kinase PERK leads to phosphorylation of the translation initiation factor eIF2 alpha, followed by partial activation of caspase-8 (but not caspase-3), caspase-8-mediated cleavage of the ER protein BAP31 and conformational activation of Bax and Bak. Finally, a pool of CRT that has transited the Golgi apparatus is secreted by SNARE-dependent exocytosis. Knock-in mutation of eIF2 alpha (to make it non-phosphorylatable) or BAP31 (to render it uncleavable), depletion of PERK, caspase-8, BAP31, Bax, Bak or SNAREs abolished CRT/ERp57 exposure induced by anthracyclines, oxaliplatin and ultraviolet C light. Depletion of PERK, caspase-8 or SNAREs had no effect on cell death induced by anthracyclines, yet abolished the immunogenicity of cell death, which could be restored by absorbing recombinant CRT to the cell surface.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据